You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment

 

Online download statistics by month:

Online download statistics by month: September 2023 to April 2025

AbstractFullPdf
Sep 202350502
Oct 2023581579249
Nov 2023236236108
Dec 202310811072
Jan 2024144145115
Feb 202410710788
Mar 2024113114141
Apr 2024979785
May 2024878869
Jun 2024727162
Jul 202412512673
Aug 2024114115117
Sep 20249294203
Oct 20248585124
Nov 202410410581
Dec 202416917291
Jan 2025989857
Feb 202515915980
Mar 2025138138119
Apr 202510410467
Total278327932003